Event Participants
Executives
5 Ashish Saraf (Chairman & Managing Director), Ashok Jain (Director & CFO), Pankaj Arati (DGM Accounts and Finance), Ekta Soni (AVP Investor Relations), Deepak Sharma (Company Secretary)
Analysts
12 Abhi Jain (AJ Capital), Akhil Gupta (360 ONE), Akshay Kaila (AK Investment), Deepali Bansal (Ventura Enterprises), Disha Chamriya (Trinetra Asset Managers), Divyansh Thakur (Finterest Capital), Kumar Somnath (Ambit Capital), Madhu Agarwal (Agarwal Family Office), Nishita (Namaspay Capital), Omkar Ghugardare (Shree Investments), Rishabh Mehra (Demeter Advisors), Rohan Mehta (Ficom Family Office), Roshan Nair (Antique Stock Broking), Sandeep Abhang (LKP Securities), Utkarsh Chanana (SMC Private Wealth)
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue | ₹404 crore | +39.5% YoY; driven by richer product mix of value-added offerings and higher traction of expanded fractionating capacity |
| EBITDA | ₹106 crore | +42.2% YoY; margin expanded 49 bps to 26.3% on disciplined cost management and operating leverage |
| PAT | ₹79 crore | +67.6% YoY; PAT margin expanded 326 bps to 19.5% on optimized product mix and operational efficiencies |
| Export:Domestic Mix | 60:40 | Versus ~55-60% export range in Q1 FY26; reflects continued strength of global customer base |
| Gross Margin Range | 45-50% | Historically consistent range; dependent on freight costs, timing, and byproduct (de-oiled cake) realization |
| Capacity Utilization | ~80% | Q1 utilization on current capacity; expected to reach 80-85% for full year FY27 post-debottlenecking |
| Raw Material Procurement | ~50% of sales | Consistent range; largely completed for Indian domestic seeds (saal, mango); shea nuts sourced from African countries |
Geographic & Segment Commentary
Export Markets (60% of Revenue): Revenue growth was approximately 85% volume-led on a YoY basis. Company supplies to more than 30 countries with diversified shipping routes across Africa, Malaysia, Indonesia, and other regions, providing resilience against geopolitical disruptions. Brazil operations commenced trial production in the prior quarter with gradual ramp-up expected over 2-4 quarters.
Domestic Market (40% of Revenue): Healthy domestic demand alongside exports; sourcing includes saal, mango, and other exotic seeds from different parts of India. Domestic seeds and butters contribute approximately 40-50% of raw material mix.
Africa Sourcing Operations: Company operates 10 wholly-owned subsidiaries across Africa. New subsidiary incorporated in Chad (Savanna Agro Chad S.A.L.) for sourcing shea nuts and butters. Acquisition of ~10 hectares (24 acres) in Burkina Faso for shea nut and mango nut processing facility, with regulatory approvals in progress. Nigeria's temporary export ban on sheanuts not material given diversified African presence.
Value-Added Products (CBE & Stearin): Contribution split is approximately 70% cocoa butter equivalent (CBE) and 30% stearin, which are technically similar products. Products are formulated based on specific customer specifications for confectionery, chocolate, and cosmetics applications.
Company-Specific & Strategic Commentary
West Africa Expansion: Incorporated wholly-owned subsidiary in Chad and acquired 24 acres in Burkina Faso for processing facility. These initiatives enhance sourcing security, traceability, supply chain resilience, and proximity to key customers while reinforcing leadership across the shea value chain.
Forward Integration - CBA Technology: Setting up enzymatic cocoa butter alternative (CBA) plant that converts liquid fractions into solid fractions using enzymes. This forward integration enables conversion of existing raw materials and byproducts (olein) into higher-value specialty fats, expanding addressable market in chocolate, confectionery, and food applications.
Backward Integration - Burkina Faso Facility: Upcoming seed processing and extraction facilities in Raipur and Burkina Faso expected to enhance value capture and improve margins. Burkina Faso plant capex of ₹120-130 crore with expected payback period of around 3 years once operational.
R&D & Innovation: Milkoa Research and Development Center, recognized by the Department of Scientific and Industrial Research (DSIR), Government of India, continues to drive product innovation. R&D capabilities are pivotal in shaping integration strategy and developing value-added products from existing portfolio.
QIP Fundraise: Successfully completed Qualified Institutional Placement (QIP) of approximately ₹500 crore, strengthening balance sheet and providing financial flexibility to accelerate growth across manufacturing, sourcing, and high value-added segments.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Debottlenecking Capacity | +4,500 tons in Q3 FY27 | Incremental capacity from debottlenecking; current capacity of 47,500 tons to reach ~52,000 tons; cost of ₹5-6 crore |
| Capacity Utilization | 80-85% for FY27 | Management internal target is 80-85%; stakeholder guidance is 80% on 52,000 tons capacity |
| Greenfield Capex Commissioning | Q3 FY28 (tentative) | Solvent fractionation and refinery in India; extraction/expelling in Burkina Faso; full impact visible in FY29 |
| FY27 Capex Spend | ₹225-250 crore | Out of total ₹460 crore proposed Capex plan; ₹17 crore already spent, ~₹220 crore remaining for FY27 |
| Employee Cost Run Rate | ₹14-15 crore per quarter | Normalized run rate excluding prior quarter's performance incentive provisions |
| QIP Utilization | Not fully deployed | ₹500 crore raised; ₹150+ crore in FDRs (excluding QIP component); QIP proceeds held for strategic investments |
Risks & Constraints
| Risk | Context |
|---|---|
| Supplier Quality Issue | Company raised a debit note against a manufacturer/supplier for a defective material; process to recover full amount underway. Company has diversified supplier base and is not dependent on the specific supplier. |
| Nigeria Sheanut Export Ban | Temporary export ban on sheanuts in Nigeria, one of 22 African countries where sheanuts are grown. Mitigated by presence in 10 African regions and multiple sourcing countries; not material to sourcing strategy. |
| Geopolitical & Freight Disruptions | Multiple geopolitical tensions impacting freight, logistics, and other macroeconomic factors. Company navigates through diversified sourcing (Africa, Malaysia, Indonesia) and exports to 30+ countries; indirect impact on freight and container costs noted (other expenses up 16%). |
| Raw Material Inflation | Pricing broadly stable but raw material cost inflation needs to be passed through costing model; gross margins range 45-50% subject to freight cost timing and byproduct realization. |
| Subsidiary Drag on Consolidated Margins | West African entities are procurement vehicles with no standalone revenue; Brazil in build-out phase. Deliberate funded investments expected to reduce drag over time and turn into contributors. |
| FX Hedging Policy | Company hedges 50-60% of net exposure historically; natural hedge from imports and exports. Q1 other income included ₹13 crore forex gain out of ₹16 crore total. |
Q&A Highlights
Capacity Expansion & Commissioning Timeline
- Question: When will the incremental 4,510 tons from debottlenecking come online, and when is the greenfield capacity expected? (Kumar Somnath - Ambit Capital)
- Answer: Debottlenecking partially operationalized; balance expected in Q3 FY27. Greenfield solvent fractionation and refinery targeted for commissioning around Q3 FY28. Burkina Faso land acquired with regulatory approvals in progress. (Ekta Soni)
Downstream Opportunities & CBA Technology
- Question: What are the downstream opportunities being explored? (Kumar Somnath - Ambit Capital)
- Answer: Expansion involves CBA (cocoa butter alternative) plant using enzymatic technology to convert liquid fractions into solid fractions. R&D team working on value-added products from byproducts like olein and other specialty fats/butters. (Ekta Soni)
Revenue Growth Decomposition
- Question: Of the 39% YoY growth, how much was volume, forex, and realization? (Madhu Agarwal - Agarwal Family Office)
- Answer: Approximately 85% of the YoY growth was volume-led. (Ekta Soni)
Margin Sustainability
- Question: Are current margins sustainable or was this an exceptional quarter? (Madhu Agarwal - Agarwal Family Office)
- Answer: Margins can see modest quarter-to-quarter movement depending on mix and one-off items, but underlying range expected to hold broadly stable. Management emphasized business risk exists but model is robust. (Ekta Soni)
Nigeria Export Ban Risk
- Question: How will Nigeria's sheanut export ban impact sourcing? (Rishabh Mehra - Demeter Advisors)
- Answer: Nigeria is one of 22 African countries growing sheanuts. Company operates in 10 African regions with multiple sourcing points. Temporary ban does not materially impact sourcing strategy given vast geographic presence. (Ekta Soni)
CBA Product Differentiation
- Question: What is the planned CBA product and how is it different from current CBE/stearin? (Rishabh Mehra - Demeter Advisors)
- Answer: CBA is enzymatic cocoa butter equivalent (ECBE) technology converting liquid fractions to solid fractions. Applications in chocolate, confectionery, and food segments. This is a forward integration enabling use of existing raw materials. (Ekta Soni)
Subsidiary Losses & One-Time Costs
- Question: Subsidiary losses declined from ₹8 crore to ₹3 crore; can you explain? (Akhil Gupta - 360 ONE)
- Answer: Prior quarter included one-time costs in subsidiaries; current losses are normal operational costs. West African entities are procurement vehicles without standalone revenue, and Brazil is in build-out phase. These are deliberate funded investments expected to turn into contributors over time. (Ekta Soni)
Other Income Breakdown
- Question: Other income of ₹16 crore - how much is forex and how should we model it going forward? (Akhil Gupta - 360 ONE & Rohan Mehta - Ficom Family Office)
- Answer: ₹13 crore forex gain and ₹3 crore FDR income. Not related to QIP proceeds. Hedging policy historically 50-60% of net exposure with natural hedge from import/export activities. Other income should normalize. (Ekta Soni)
Capex Spend & Working Capital Requirements
- Question: How will the ₹460 crore capex be funded given working capital requirements? (Abhi Jain - AJ Capital)
- Answer: ₹17 crore spent to date; ~₹220 crore planned for FY27. Working capital funded through existing bankers (SBI lead banker), ₹500 crore QIP proceeds, and ₹150+ crore FDRs. No further equity dilution planned in near term. (Ekta Soni)
Brazil Ramp-Up Timeline
- Question: How long for Brazil commercial production to fully ramp up? (Roshan Nair - Antique Stock Broking)
- Answer: Trial production started last quarter; product dispatched from Indian plant for processing. Gradual ramp-up expected over next 2-4 quarters. Specific revenue contribution guidance not yet available. (Ekta Soni)
Key Takeaway
Manorama Industries delivered a strong Q1 FY27 with revenue of ₹404 crore (+39.5% YoY), EBITDA of ₹106 crore (26.3% margin, +49 bps), and PAT of ₹79 crore (19.5% margin, +326 bps), crossing the ₹4,000 million quarterly revenue plateau for the first time. Growth was approximately 85% volume-led with export:domestic mix at 60:40. Strategic focus centers on backward integration via African sourcing subsidiaries (Chad incorporation, Burkina Faso land acquisition for ₹120-130 crore processing facility) and forward integration through enzymatic CBA technology. With QIP proceeds of ~₹500 crore, FDRs of ₹150+ crore, and bank lines led by SBI, the company is well-funded for its ₹460 crore capex program spanning FY27-FY28. Management guides to 80-85% utilization on ~52,000 tons capacity for FY27, with debottlenecking (+4,500 tons) in Q3 FY27 and greenfield commissioning around Q3 FY28, with full contribution visibility in FY29. Key watch points include supplier quality recovery, Nigeria export ban impact (deemed immaterial), and subsidiary profitability as procurement entities scale.